United States · FDA National Drug Code directory

Gabapentin

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 69097-812_69887d93-de9a-4397-a629-a0ce8e62c69a
Product NDC: 69097-812
Form: TABLET
Composition / generic term: Gabapentin
Labeler: Cipla USA Inc.
Marketing category: ANDA
Marketing start / end (source format): 20160722
Source listing expiry: 20261231

Source-listed ingredients

GABAPENTIN — 600 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

30 TABLET in 1 BOTTLE (69097-812-02) · 69097-812-02
100 TABLET in 1 BOTTLE (69097-812-07) · 69097-812-07
500 TABLET in 1 BOTTLE (69097-812-12) · 69097-812-12

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →